Located in Florida, the new plant will be fully operational by Q1 2023 and will be part of the company’s Funtrition by Procaps business division.
Procaps Group, a pharmaceutical and dietary supplement manufacturer headquartered in Latin America, will open a new gummy manufacturing facility in the U.S. to meet growing U.S. and global demand for nutraceutical and specialized gummy products, the firm said. Located in Florida, the new plant will be fully operational by Q1 2023 and will be part of the company’s Funtrition by Procaps business division dedicated to developing unique nutraceutical gummy formulations, flavors, and textures. The company says it has more than 20 years of experience manufacturing gummy products.
The new plant will double the company’s gummies manufacturing capacity. The new plant is modeled after Procaps’s state-of-the-art gummy manufacturing plant in Bogota, Colombia.
“This new facility is expected to substantially increase our capacity for the first time outside of Procaps Group’s Colombian headquarters for the manufacture of animal- and plant-based nutraceutical gummies,” said Camilo Camacho, Procaps group president, in a press release. “The U.S. location will ensure redundancy in supply to the market and position manufacturing of a wider product array closer to key current and potential new customers. The higher production capacities are expected to also be a significant addition to our global growth plans.”
“Complementing our recent West Palm Beach, Florida, acquisition, the expansion of our U.S. capacity for our Funtrition business is an important step towards our commitment to meet the requirements of our growing base of U.S. customers,” added Ruben Minski, Procaps group CEO, in the press release. “Our new Inspiration Center is a critical piece in our value proposition, underscoring our commitment to deliver better health and nutrition to the world through innovative oral delivery systems. Taken together, we believe these long-term investments will further position Funtrition as a leader in extraordinary and enjoyable gummy products and position us to capture emerging growth opportunities within the space.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.